Your browser doesn't support javascript.
loading
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.
Heinicke, Ulrike; Adam, Elisabeth; Sonntagbauer, Michael; von Knethen, Andreas; Zacharowski, Kai; Neb, Holger.
Afiliação
  • Heinicke U; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Adam E; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Sonntagbauer M; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • von Knethen A; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Zacharowski K; Fraunhofer - IME, Project Group Translational Medicine and Pharmacology (TMP), Frankfurt am Main, Germany.
  • Neb H; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
Crit Care ; 24(1): 409, 2020 07 09.
Article em En | MEDLINE | ID: mdl-32646469
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angiotensina II Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Crit Care Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angiotensina II Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Crit Care Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha